{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:45:28Z","timestamp":1793727928438,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870524"],"award-info":[{"award-number":["81870524"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03199-1","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T03:24:50Z","timestamp":1664767490000},"page":"180-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Roxadustat improves renal osteodystrophy by dual regulation of bone remodeling"],"prefix":"10.1007","volume":"79","author":[{"given":"Luyao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangying","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"1","key":"3199_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"KDIGO 2017","year":"2017","unstructured":"KDIGO 2017, clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. (2011) 7(1), 1\u201359 (2017)","journal-title":"Kidney Int Suppl. (2011)"},{"issue":"4","key":"3199_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1053\/j.ajkd.2020.12.024","volume":"78","author":"M Pazianas","year":"2021","unstructured":"M. Pazianas, P.D. Miller, Osteoporosis and chronic kidney disease-mineral and bone disorder (CKD-MBD): back to basics. Am. J. Kidney Dis. 78(4), 582\u2013589 (2021)","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"3199_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.ajkd.2021.06.031","volume":"79","author":"C Ginsberg","year":"2022","unstructured":"C. Ginsberg, J.H. Ix, Diagnosis and management of osteoporosis in advanced kidney disease: a review. Am. J. Kidney Dis. 79(3), 427\u2013436 (2022)","journal-title":"Am. J. Kidney Dis."},{"key":"3199_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1749-6632.2009.05236.x","volume":"1192","author":"E Schipani","year":"2010","unstructured":"E. Schipani, Posttranslational modifications of collagens as targets of hypoxia and Hif-1\u03b1 in endochondral bone development. Ann. N. Y Acad. Sci. 1192, 317\u2013321 (2010)","journal-title":"Ann. N. Y Acad. Sci."},{"key":"3199_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bone.2017.08.022","volume":"115","author":"S Stegen","year":"2018","unstructured":"S. Stegen, G. Carmeliet, The skeletal vascular system - breathing life into bone tissue. Bone 115, 50\u201358 (2018)","journal-title":"Bone"},{"issue":"6","key":"3199_CR6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1172\/JCI31581","volume":"117","author":"Y Wang","year":"2007","unstructured":"Y. Wang, C. Wan, L. Deng, X. Liu, X. Cao, S.R. Gilbert et al. The hypoxia-inducible factor \u03b1 pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest 117(6), 1616\u20131626 (2007)","journal-title":"J. Clin. Invest"},{"key":"3199_CR7","doi-asserted-by":"publisher","first-page":"582670","DOI":"10.3389\/fendo.2020.582670","volume":"11","author":"L Zhang","year":"2021","unstructured":"L. Zhang, L. Jin, J. Guo, K. Bao, J. Hu, Y. Zhang et al. Chronic intermittent hypobaric hypoxia enhances bone fracture healing. Front Endocrinol. (Lausanne) 11, 582670 (2021)","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"2","key":"3199_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1073\/pnas.0708474105","volume":"105","author":"C Wan","year":"2008","unstructured":"C. Wan, S.R. Gilbert, Y. Wang, X. Cao, X. Shen, G. Ramaswamy et al. Activation of the hypoxia-inducible factor-1\u03b1 pathway accelerates bone regeneration. Proc. Natl. Acad. Sci. USA 105(2), 686\u2013691 (2008)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"3199_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1101\/gad.255000.114","volume":"29","author":"C Wu","year":"2015","unstructured":"C. Wu, E.B. Rankin, L. Castellini, J.F. Alcudia, E.L. LaGory, R. Andersen et al. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. Genes Dev. 29(8), 817\u2013831 (2015)","journal-title":"Genes Dev."},{"issue":"3","key":"3199_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bone.2011.12.003","volume":"50","author":"Q Zhao","year":"2012","unstructured":"Q. Zhao, X. Shen, W. Zhang, G. Zhu, J. Qi, L. Deng, Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. Bone 50(3), 763\u2013770 (2012)","journal-title":"Bone"},{"issue":"1","key":"3199_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13287-020-02112-9","volume":"12","author":"L Yi","year":"2021","unstructured":"L. Yi, Y. Ju, Y. He, X. Yin, Y. Xu, T. Weng, Intraperitoneal injection of Desferal\u00ae alleviated the age-related bone loss and senescence of bone marrow stromal cells in rats. Stem Cell Res Ther. 12(1), 45 (2021)","journal-title":"Stem Cell Res Ther."},{"key":"3199_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bone.2018.10.025","volume":"120","author":"C Guo","year":"2019","unstructured":"C. Guo, K. Yang, Y. Yan, D. Yan, Y. Cheng, X. Yan et al. SF-deferoxamine, a bone-seeking angiogenic drug, prevents bone loss in estrogen-deficient mice. Bone 120, 156\u2013165 (2019)","journal-title":"Bone"},{"issue":"1","key":"3199_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12013-013-9780-8","volume":"69","author":"X Liu","year":"2014","unstructured":"X. Liu, Y. Tu, L. Zhang, J. Qi, T. Ma, L. Deng, Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity. Cell Biochem Biophys. 69(1), 141\u2013149 (2014)","journal-title":"Cell Biochem Biophys."},{"issue":"11","key":"3199_CR14","doi-asserted-by":"publisher","first-page":"e112744","DOI":"10.1371\/journal.pone.0112744","volume":"9","author":"J Peng","year":"2014","unstructured":"J. Peng, Z.G. Lai, Z.L. Fang, S. Xing, K. Hui, C. Hao et al. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL\/6J mice through enhanced angiogenesis and osteogenesis. PLoS One 9(11), e112744 (2014)","journal-title":"PLoS One"},{"issue":"5","key":"3199_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","volume":"79","author":"S Dhillon","year":"2019","unstructured":"S. Dhillon, Roxadustat: first global approval. Drugs 79(5), 563\u2013572 (2019)","journal-title":"Drugs"},{"issue":"16","key":"3199_CR16","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","volume":"61","author":"AA Joharapurkar","year":"2018","unstructured":"A.A. Joharapurkar, V.B. Pandya, V.J. Patel, R.C. Desai, M.R. Jain, Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases. J. Med Chem. 61(16), 6964\u20136982 (2018)","journal-title":"J. Med Chem."},{"issue":"7","key":"3199_CR17","first-page":"e10370","volume":"4","author":"PA Hulley","year":"2020","unstructured":"P.A. Hulley, I. Papadimitriou-Olivgeri, H.J. Knowles, Osteoblast-osteoclast coculture amplifies inhibitory effects of FG-4592 on human osteoclastogenesis and reduces bone resorption. JBMR 4(7), e10370 (2020)","journal-title":"JBMR"},{"key":"3199_CR18","doi-asserted-by":"publisher","first-page":"118684","DOI":"10.1016\/j.lfs.2020.118684","volume":"264","author":"C Chen","year":"2021","unstructured":"C. Chen, S. Yan, S. Qiu, Z. Geng, Z. Wang, HIF\/Ca2+\/NO\/ROS is critical in roxadustat treating bone fracture by stimulating the proliferation and migration of BMSCs. Life Sci. 264, 118684 (2021)","journal-title":"Life Sci."},{"issue":"11","key":"3199_CR19","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","volume":"123","author":"PG Reeves","year":"1993","unstructured":"P.G. Reeves, F.H. Nielsen, G.C. Fahey Jr, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123(11), 1939\u20131951 (1993)","journal-title":"J. Nutr."},{"issue":"7","key":"3199_CR20","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"M.L. Bouxsein, S.K. Boyd, B.A. Christiansen, R.E. Guldberg, K.J. Jepsen, R. M\u00fcller, Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Min. Res 25(7), 1468\u20131486 (2010)","journal-title":"J. Bone Min. Res"},{"issue":"1","key":"3199_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"D.W. Dempster, J.E. Compston, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Min. Res 28(1), 2\u201317 (2013)","journal-title":"J. Bone Min. Res"},{"issue":"2","key":"3199_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00223-021-00910-8","volume":"110","author":"AC Ferreira","year":"2022","unstructured":"A.C. Ferreira, P. Cotovio, I. Aires, M. Mendes, D. Navarro, C. Silva et al. The role of bone volume, FGF23 and sclerostin in calcifications and mortality; a cohort study in CKD stage 5 patients. Calcif. Tissue Int. 110(2), 215\u2013224 (2022)","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"3199_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000452880","volume":"3","author":"X Lu","year":"2017","unstructured":"X. Lu, M.C. Hu, Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease. Kidney Dis. (Basel) 3(1), 15\u201323 (2017)","journal-title":"Kidney Dis. (Basel)"},{"issue":"5","key":"3199_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"S. Singh, A. Grabner, C. Yanucil, K. Schramm, B. Czaya, S. Krick et al. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int 90(5), 985\u2013996 (2016)","journal-title":"Kidney Int"},{"issue":"11","key":"3199_CR25","doi-asserted-by":"publisher","first-page":"e14434","DOI":"10.14814\/phy2.14434","volume":"8","author":"ML Noonan","year":"2020","unstructured":"M.L. Noonan, E.L. Clinkenbeard, P. Ni, E.A. Swallow, S.P. Tippen, R. Agoro et al. Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD). Physiol. Rep. 8(11), e14434 (2020)","journal-title":"Physiol. Rep."},{"issue":"4","key":"3199_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00467-021-05191-9","volume":"37","author":"E Patino","year":"2022","unstructured":"E. Patino, O. Akchurin, Erythropoiesis-independent effects of iron in chronic kidney disease. Pediatr. Nephrol. 37(4), 777\u2013788 (2022)","journal-title":"Pediatr. Nephrol."},{"key":"3199_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2017.00077","volume":"8","author":"V Jeney","year":"2017","unstructured":"V. Jeney, Clinical impact and cellular mechanisms of iron overload-associated bone loss. Front Pharm. 8, 77 (2017)","journal-title":"Front Pharm."},{"issue":"4","key":"3199_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/ph11040107","volume":"11","author":"E Balogh","year":"2018","unstructured":"E. Balogh, G. Paragh, V. Jeney, Influence of iron on bone homeostasis. Pharm. (Basel) 11(4), 107 (2018)","journal-title":"Pharm. (Basel)"},{"issue":"9","key":"3199_CR29","doi-asserted-by":"publisher","first-page":"9828","DOI":"10.1096\/fj.201802242RR","volume":"33","author":"Z Liu","year":"2019","unstructured":"Z. Liu, K. Yang, X. Yan, T. Wang, T. Jiang, Q. Zhou et al. The effects of tranylcypromine on osteoclastogenesis in vitro and in vivo. FASEB J. 33(9), 9828\u20139841 (2019)","journal-title":"FASEB J."},{"issue":"5","key":"3199_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/jbmr.3957","volume":"35","author":"YM Zhou","year":"2020","unstructured":"Y.M. Zhou, Y.Y. Yang, Y.X. Jing, T.J. Yuan, L.H. Sun, B. Tao et al. BMP9 reduces bone loss in ovariectomized mice by dual regulation of bone remodeling. J. Bone Min. Res 35(5), 978\u2013993 (2020)","journal-title":"J. Bone Min. Res"},{"issue":"11","key":"3199_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","volume":"381","author":"N Chen","year":"2019","unstructured":"N. Chen, C. Hao, B.C. Liu, H. Lin, C. Wang, C. Xing et al. Roxadustat treatment for anemia in patients undergoing long-term dialysis. N. Engl. J. Med 381(11), 1011\u20131022 (2019)","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"3199_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1681\/ASN.2020081150","volume":"32","author":"S Fishbane","year":"2021","unstructured":"S. Fishbane, M.A. El-Shahawy, R. Pecoits-Filho, B.P. Van, M.T. Houser, L. Frison et al. Roxadustat for treating anemia in patients with CKD not on dialysis: results from a randomized phase 3 study. J. Am. Soc. Nephrol. 32(3), 737\u2013755 (2021)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"3199_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2215\/CJN.06890615","volume":"11","author":"R Provenzano","year":"2016","unstructured":"R. Provenzano, A. Besarab, C.H. Sun, S.A. Diamond, J.H. Durham, J.L. Cangiano et al. Oral hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) for the treatment of anemia in patients with CKD. Clin. J. Am. Soc. Nephrol. 11(6), 982\u2013991 (2016)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"3199_CR34","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2215\/CJN.16191020","volume":"16","author":"R Provenzano","year":"2021","unstructured":"R. Provenzano, L. Szczech, R. Leong, K.G. Saikali, M. Zhong, T.T. Lee et al. Efficacy and cardiovascular safety of roxadustat for treatment of anemia in patients with non-dialysis-dependent CKD: pooled results of three randomized clinical trials. Clin. J. Am. Soc. Nephrol. 16(8), 1190\u20131200 (2021)","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03199-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:33:50Z","timestamp":1672853630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03199-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["3199"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03199-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal experiment was performed in compliance with the Guide for the Care and Use of Laboratory Animals issued by the US National Institute of Health (NIH Publication NO. 85-23). All animal procedures were approved by the Institutional Authority for Laboratory Animal Care of Peking University People\u2019s Hospital (approval number: 2020PHE039).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}